检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:何庚戌[1] 要彤[2] 刘俊堂[3] 李海英[1] 周峰[1] 濮仁富[1] 徐昌富[1] 蔡宝松[1] 张雁[1]
机构地区:[1]解放军251医院胸心血管外科,河北张家口075000 [2]河北北方学院第一附属医院心电图室,河北张家口075000 [3]解放军251医院麻醉科,河北张家口075000
出 处:《解放军医药杂志》2013年第10期64-66,共3页Medical & Pharmaceutical Journal of Chinese People’s Liberation Army
摘 要:目的探讨应用牛颈静脉行上腔静脉置换治疗上腔静脉阻塞综合征的可行性。方法 2008年2月—2011年5月收治胸部肿瘤侵犯上腔静脉引起上腔静脉阻塞综合征12例,均应用牛颈静脉置换受肿瘤侵犯的上腔静脉。结果本组术后均恢复顺利,术后12~36 h上腔静脉阻塞症状缓解。术后所有患者接受化疗,2例恶性胸腺瘤术后6个月接受局部放疗。牛颈静脉1年通畅率为100%。1例肺癌术后18个月肿瘤复发未接受治疗,1例肺癌和2例恶性胸腺瘤均于术后24个月死亡。随访期间未见移植的牛颈静脉内血栓形成及钙化。结论应用戊二醛处理的牛颈静脉对胸部肿瘤引起的上腔静脉阻塞综合征行上腔静脉置换治疗安全可行。Objective To investigate the feasibility of replacement of superior vena cava by using bovine jugular veins in treatment of superior vena eaval obstruction syndrome. Methods Twelve patients with superior vena eaval ob- struction syndrome induced by thoracic neoplasms encroachment admitted during February 2008 and May 2011 underwent the replacement of encroachment of superior vena cava by using bovine jugular veins. Results Operation treatments suc- cessfully recuperated all patients, and symptoms of superior vena cava were relieved postoperative 12 -36 h. All patients underwent postoperative chemotherapy, and 2 patients with malignant thymoma underwent part radiotherapy 6 months af- ter operation. One year of patency rate of bovine jugular veins was 100%. One patient with pulmonary cancer relapsed 18 months after operation without treatment, one patient with puhnonary cancer and 2 patients with malignant thymoma died 24 months after operation. There was no thrombus or calcification in transplanted bovine jugular veins during the follow- up period. Conclusion Replacement of superior vena eava by using bovine jugular vein treated with glutaral in treatment of superior vena eaval obstruction syndrome is feasible and safe.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249